NCT00218127View on ClinicalTrials.gov

Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing Regimens

PHASE2CompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions
Heroin DependenceOpioid-Related Disorders
Interventions
DRUG

Levoacetyl Methadol

WtDosing up to 1.0 mg/kg Stable 1.0 mg/kg/day

DRUG

Levoacetyl Methadol

MaxEffect+CBT evaluation to 48 mg Adjust to effect (+/-)

DRUG

Levoacetyl Methadol

LAAM Fixed Dose evaluation up to 48 mg 48 mg

Trial Locations (1)

77030

Department of Psychatiry, Mental Services, Houston

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00218127 - Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing Regimens | Biotech Hunter | Biotech Hunter